Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

M Cote

Showing results (131-140 of 213) with videos related to

Pageof 22
Sort By:
Cancer|December 25, 2014
Phase 1 study of oral abexinostat, a histone deacetylase inhibitor, in combination with doxorubicin in patients with metastatic sarcomaEdwin Choy, Yael Flamand, Sriram Balasubramanian, et al.
Radiotherapy and Oncology : Journal of the European Society for Therapeutic Radiology and Oncology|April 16, 2022
Definitive high-dose, proton-based radiation for unresected mobile spine and sacral chordomasWalter Banfield, Myrsini Ioakeim-Ioannidou, Saveli Goldberg, et al.
The Oncologist|March 8, 2018
A First-in-Human Phase I Study of OPB-111077, a Small-Molecule STAT3 and Oxidative Phosphorylation Inhibitor, in Patients with Advanced CancersAnthony Tolcher, Keith Flaherty, Geoffrey I Shapiro, et al.
Neuroscience Letters|December 21, 2013
Cerebrovascular perfusion among older adults is moderated by strength training and genderXiaomeng Xu, Beth A Jerskey, Denise M Cote, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|October 25, 2024
A Translational Study of the ATR Inhibitor Berzosertib as Monotherapy in Four Molecularly Defined Cohorts of Advanced Solid TumorsGregory M Cote, Bose S Kochupurakkal, Khanh Do, et al.
International Journal of Radiation Oncology, Biology, Physics|August 31, 2018
Characteristics and Predictors for Secondary Leukemia and Myelodysplastic Syndrome in Ewing and Osteosarcoma SurvivorsNina N Sanford, Ruoyu Miao, Haotong Wang, et al.
Gynecologic Oncology|November 10, 2012
Correlation of tumor size with other prognostic factors in uterine serous carcinoma: a large multi-institutional studyI Winer, H Mahdi, S Bandyopadhyay, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|January 18, 2024
Phase II Study of Eribulin plus Pembrolizumab in Metastatic Soft-tissue Sarcomas: Clinical Outcomes and Biological CorrelatesCandace L Haddox, Michael J Nathenson, Emanuele Mazzola, et al.
Blood|November 8, 2019
Genomic analyses of PMBL reveal new drivers and mechanisms of sensitivity to PD-1 blockadeBjoern Chapuy, Chip Stewart, Andrew J Dunford, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology|October 16, 2014
Active and passive smoking in relation to lung cancer incidence in the Women's Health Initiative Observational Study prospective cohortA Wang, J Kubo, J Luo, et al.
Pageof 22

Showing results (131-140 of 213) with videos related to

Sort By:
Pageof 22
Cancer|December 25, 2014
Phase 1 study of oral abexinostat, a histone deacetylase inhibitor, in combination with doxorubicin in patients with metastatic sarcomaEdwin Choy, Yael Flamand, Sriram Balasubramanian, et al.
Radiotherapy and Oncology : Journal of the European Society for Therapeutic Radiology and Oncology|April 16, 2022
Definitive high-dose, proton-based radiation for unresected mobile spine and sacral chordomasWalter Banfield, Myrsini Ioakeim-Ioannidou, Saveli Goldberg, et al.
The Oncologist|March 8, 2018
A First-in-Human Phase I Study of OPB-111077, a Small-Molecule STAT3 and Oxidative Phosphorylation Inhibitor, in Patients with Advanced CancersAnthony Tolcher, Keith Flaherty, Geoffrey I Shapiro, et al.
Neuroscience Letters|December 21, 2013
Cerebrovascular perfusion among older adults is moderated by strength training and genderXiaomeng Xu, Beth A Jerskey, Denise M Cote, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|October 25, 2024
A Translational Study of the ATR Inhibitor Berzosertib as Monotherapy in Four Molecularly Defined Cohorts of Advanced Solid TumorsGregory M Cote, Bose S Kochupurakkal, Khanh Do, et al.
International Journal of Radiation Oncology, Biology, Physics|August 31, 2018
Characteristics and Predictors for Secondary Leukemia and Myelodysplastic Syndrome in Ewing and Osteosarcoma SurvivorsNina N Sanford, Ruoyu Miao, Haotong Wang, et al.
Gynecologic Oncology|November 10, 2012
Correlation of tumor size with other prognostic factors in uterine serous carcinoma: a large multi-institutional studyI Winer, H Mahdi, S Bandyopadhyay, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|January 18, 2024
Phase II Study of Eribulin plus Pembrolizumab in Metastatic Soft-tissue Sarcomas: Clinical Outcomes and Biological CorrelatesCandace L Haddox, Michael J Nathenson, Emanuele Mazzola, et al.
Blood|November 8, 2019
Genomic analyses of PMBL reveal new drivers and mechanisms of sensitivity to PD-1 blockadeBjoern Chapuy, Chip Stewart, Andrew J Dunford, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology|October 16, 2014
Active and passive smoking in relation to lung cancer incidence in the Women's Health Initiative Observational Study prospective cohortA Wang, J Kubo, J Luo, et al.
Pageof 22